Insider Transactions in Q2 2023 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.31%
|
$50,000
$2.45 P/Share
|
|
Jun 30
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-5.67%
|
$60,000
$8.82 P/Share
|
|
Jun 29
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-5.37%
|
$60,000
$8.97 P/Share
|
|
Jun 28
2023
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-6.68%
|
$80,000
$8.99 P/Share
|
|
May 19
2023
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,758
-2.72%
|
$12,306
$7.36 P/Share
|
|
Apr 17
2023
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-2.92%
|
$7,888
$8.34 P/Share
|
|
Apr 17
2023
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+4.79%
|
$3,400
$2.94 P/Share
|